Mitochondrial Telomerase Prevents Chemotherapy-Induced Cardiovascular Toxicity

被引:0
|
作者
Brandt, Lukas
Hader, Shelby N.
Toro, Laura E. Norwood
Gutterman, David D.
Beyer, Andreas M.
机构
[1] Medicine, Medical College of Wisconsin, WI, Wauwatosa
[2] Cardiovascular Center, Medical College of Wisconsin, WI, Wauwatosa
[3] Physiology, Medical College of Wisconsin, WI, Wauwatosa
[4] Cancer Center, Medical College of Wisconsin, WI, Wauwatosa
来源
FASEB JOURNAL | 2022年 / 36卷
关键词
D O I
10.1096/fasebj.2022.36.S1.R4146
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anti-cancer therapy (including doxorubicin (Dox)) is frequently used to combat growth of tumors. Chemotherapy (CTx) induced cardiotoxicity manifests as cardiomyopathy and can ultimately progress to heart failure and significantly contributes to morbidity and mortality among cancer survivors. Limited evidence demonstrates the impact of Dox on vascular endothelial function and possible contribution to progression of heart failure. TERT, the catalytic subunit of telomerase, has been increasingly recognized for its benificial effects on vascular quiescence via suppression of mitochondrial ROS to maintain mitochondrial integrity. Anthracycline treatment (e.g., Dox) correlates with both, suppressed TERT expression and activity as well as increased mitochondrial DNA damage. These combined effects of inadequate TERT levels and loss of mitochondrial integrity may contribute to CTx induced cardiotoxicity. The goal of this study was to define the contribution of TERT to CTx-induced endothelial dysfunction and to cardiac dysfunction. We hypothesize that TERT gain of function prevents, while TERT loss of function augments CTx-induced microvascular and cardiac dysfunction. We modulated TERT activation with a known telomerase activator cycloastragenol (CAG) via dietary supplement. In TERT WT animals, treatment with Dox significantly reduced endothelial dependent dilator function as early as two weeks after first dose. Dietary supplementation with CAG prevented Dox induced decrease in endothelial function (A). In contrast, in TERT-specific KO animals Dox induced vascular damage was increased and CAG treatment failed to prevent endothelial dysfunction (B). Cardiac function followed similar patterns. In WT rats Dox caused significant reductions in left ventricular ejection fraction (LVEF) six weeks after the first dose of Dox, which was prevented by dietary supplementation with CAG. The reduction in LVEF was augmented in TERT KO animals and not rescued by CAG (C). Collectively, our data showed that Dox induced endothelial dysfunction was prevented by the pharmacological activation of TERT via CAG and furthermore suggests, that Dox induced endothelial dysfunction manifests before or independent of a cardiac damage. Likewise, CAG administration was sufficient to prevent reductions in LVEF relative to baseline in Dox treated WT animals. Specificity of a TERT mediated phenotype via CAG was established by failure of rescue in TERT KO rats. Ultimately, our results indicate that CAG has the potential as therapeutic to counteract the detrimental effects of CTx in the cardiovascular system via activation of TERT. © FASEB.
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Role of Mitochondrial Mechanism in Chemotherapy-Induced Peripheral Neuropathy
    Waseem, Mohammad
    Kaushik, Pooja
    Tabassum, Heena
    Parvez, Suhel
    CURRENT DRUG METABOLISM, 2018, 19 (01) : 47 - 54
  • [32] What lies behind chemotherapy-induced ovarian toxicity?
    Ben-Aharon, Irit
    Shalgi, Ruth
    REPRODUCTION, 2012, 144 (02) : 153 - 163
  • [33] Chemotherapy-induced skin toxicity and capillary leak syndrome
    Hunjan, Manrup K.
    Nowsheen, Somaira
    Ramos-Rodriguez, Alvaro J.
    Bridges, Alina G.
    Lehman, Julia S.
    Hashmi, Shahrukh K.
    el-Azhary, Rokea A.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2019, 58 (07) : 856 - 860
  • [34] Imaging of chemotherapy-induced liver toxicity: an illustrated overview
    Torri, Giovanni Brondani
    Soldatelli, Matheus Dorigatti
    Luersen, Gustavo Felipe
    Almeida Ghezzi, Caroline Lorenzoni
    HEPATIC ONCOLOGY, 2021, 8 (04)
  • [35] The predictive value of body protein for chemotherapy-induced toxicity
    Aslani, A
    Smith, RC
    Allen, BJ
    Pavlakis, N
    Levi, JA
    CANCER, 2000, 88 (04) : 796 - 803
  • [36] Chemotherapy-Induced Pulmonary Toxicity in Lung Cancer Patients
    Ryu, Jay H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (09) : 1313 - 1314
  • [37] Exercise Preconditioning Prevents Chemotherapy-Induced Alterations to Transport Proteins Required for Mitochondrial Iron Uptake and Metabolism in the Diaphragm
    Smuder, Ashley
    Huertas, Andres
    Morton, Aaron
    FASEB JOURNAL, 2020, 34
  • [38] Role of advanced cardiovascular imaging in chemotherapy-induced cardiotoxicity
    Cannizzaro, Maria Teresa
    Inserra, Maria Cristina
    Passaniti, Giulia
    Celona, Antonio
    D'Angelo, Tommaso
    Romeo, Placido
    Basile, Antonio
    HELIYON, 2023, 9 (04)
  • [39] Cancer During Pregnancy: The Role of Vascular Toxicity in Chemotherapy-Induced Placental Toxicity
    Bar-Joseph, Hadas
    Peccatori, Fedro Alessandro
    Goshen-Lago, Tal
    Cribiu, Fulvia Milena
    Scarfone, Giovanna
    Miller, Irit
    Nemerovsky, Luba
    Levi, Mattan
    Shalgi, Ruth
    Ben-Aharon, Irit
    CANCERS, 2020, 12 (05)
  • [40] Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity
    Ben-Aharon, I.
    Granot, T.
    Meizner, I.
    Rizel, S.
    Yerushalmi, R.
    Sulkes, A.
    Stemmer, S.
    BREAST, 2012, 21 : S10 - S10